We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MR Enterography Eliminates Unnecessary Radiation Exposure in Patients with Crohn's Disease

By HospiMedica International staff writers
Posted on 26 May 2009
Magnetic resonance (MR) enterography has been shown to be an effective tool to evaluate and guide treatment of patients with Crohn's disease (a common form of inflammatory bowel disease that typically affects young people) without exposing them to radiation, according to recent research.

"MR enterography is an MR examination targeted at the small bowel. More...
The study included approximately 100 patients and 15 physicians,” said David Grand, M.D., from the Warren Alpert School of Medicine/Brown University (Providence, RI, USA), and lead author of the study. "Nearly 100% of physicians who use MR enterography reported that they found information from the test useful for guiding patient management; patients overwhelmingly preferred MR to the CT [computed tomography],” he said. "This is an ongoing study,” he added.

Crohn's disease usually effects younger individuals and will be a chronic disease throughout their life, requiring them to have multiple diagnostic imaging procedures, according to Dr. Grand. These young patients are too often exposed to multiple doses of ionizing radiation, the long-term effects of which may be quite dangerous. Moreover, patients are frequently given very effective but potentially toxic "biologic” therapies to help reduce inflammation. MR can also be used to see if these compounds are working without exposure to radiation.

"MR enterography is beneficial to the patient because it provides the same information regarding the extent of small bowel disease as CT, but we believe is superior at judging whether disease is active or chronic--all without exposing the patient to radiation. Judging whether disease is active or chronic is critical to deciding on medical versus surgical treatment and we believe MR excels at making this distinction,” said Dr. Grand. "There are many physicians who are using MR to diagnose and guide treatment of patients with Crohn's disease. MR offers an immediate and lasting effect on the management of the disease without exposing patients to radiation.”

This study was presented at the 2009 American Roentgen Ray Society (ARRS) annual meeting in Boston, MA, USA, on April 26-30, 2009.

Warren Alpert School of Medicine/Brown University


Related Links:

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Wound Irrigation Solution
Prontosan®
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.